Late preventive effects of several anticalmodulin drugs on galactosamine-induced liver necrosis. 1985

E C de Ferreyra, and O M de Fenos, and J A Castro

Four anticalmodulin drugs: trifluoperazine (TFP), pimozide (PMZ), thioridazine (TDZ) and imipramine (IMP) (50 mg/kg, ip) were able to partially prevent Galactosamine (GAL) (600 mg/kg, ip) induced liver necrosis when given 6 h after the hepatotoxin. IMP was also effective 10 h after GAL. The possibility of calmodulin participation in late stages of GAL-induced liver injury is analyzed.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D010868 Pimozide A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) Antalon,Orap,Orap forte,R-6238,R6238
D002147 Calmodulin A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels. Calcium-Dependent Activator Protein,Calcium-Dependent Regulator,Bovine Activator Protein,Cyclic AMP-Phosphodiesterase Activator,Phosphodiesterase Activating Factor,Phosphodiesterase Activator Protein,Phosphodiesterase Protein Activator,Regulator, Calcium-Dependent,AMP-Phosphodiesterase Activator, Cyclic,Activating Factor, Phosphodiesterase,Activator Protein, Bovine,Activator Protein, Calcium-Dependent,Activator Protein, Phosphodiesterase,Activator, Cyclic AMP-Phosphodiesterase,Activator, Phosphodiesterase Protein,Calcium Dependent Activator Protein,Calcium Dependent Regulator,Cyclic AMP Phosphodiesterase Activator,Factor, Phosphodiesterase Activating,Protein Activator, Phosphodiesterase,Protein, Bovine Activator,Protein, Calcium-Dependent Activator,Protein, Phosphodiesterase Activator,Regulator, Calcium Dependent
D005688 Galactosamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013881 Thioridazine A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA. Aldazine,Apo-Thioridazine,Meleril,Mellaril,Melleretten,Melleril,Melleryl,Melzine,Rideril,Sonapax,Thioridazine HCL,Thioridazine Hydrochloride,Thioridazine-Neurazpharm,Thiozine,Apo Thioridazine,ApoThioridazine,Thioridazine Neurazpharm,ThioridazineNeurazpharm
D014268 Trifluoperazine A phenothiazine with actions similar to CHLORPROMAZINE. It is used as an antipsychotic and an antiemetic. Trifluoroperazine,Triftazin,Apo-Trifluoperazine,Eskazine,Flupazine,Stelazine,Terfluzine,Trifluoperazine HCL,Trifluoperazine Hydrochloride,Trifluperazine,Apo Trifluoperazine,ApoTrifluoperazine

Related Publications

E C de Ferreyra, and O M de Fenos, and J A Castro
April 1981, Experimental and molecular pathology,
E C de Ferreyra, and O M de Fenos, and J A Castro
January 2004, BioFactors (Oxford, England),
E C de Ferreyra, and O M de Fenos, and J A Castro
July 1973, The American journal of pathology,
E C de Ferreyra, and O M de Fenos, and J A Castro
May 1984, Artificial organs,
E C de Ferreyra, and O M de Fenos, and J A Castro
May 1986, Nihon Geka Gakkai zasshi,
E C de Ferreyra, and O M de Fenos, and J A Castro
November 1985, European journal of cell biology,
E C de Ferreyra, and O M de Fenos, and J A Castro
March 2013, Journal of clinical biochemistry and nutrition,
E C de Ferreyra, and O M de Fenos, and J A Castro
January 1972, Progress in liver diseases,
E C de Ferreyra, and O M de Fenos, and J A Castro
August 1990, Hepatology (Baltimore, Md.),
E C de Ferreyra, and O M de Fenos, and J A Castro
June 1993, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine,
Copied contents to your clipboard!